BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.61% | 520.51% | 285.62% | 285.62% | 191.00% |
| Total Depreciation and Amortization | 50.48% | 77.32% | -16.28% | -16.28% | -9.74% |
| Total Amortization of Deferred Charges | 19.38% | 200.79% | -- | -- | -- |
| Total Other Non-Cash Items | -40.30% | -269.49% | 151.04% | 151.04% | 31.03% |
| Change in Net Operating Assets | 59.07% | 1,764.05% | -1,987.81% | -1,987.81% | -1,806.53% |
| Cash from Operations | 635.10% | 2,519.47% | 717.30% | 717.30% | 183.40% |
| Capital Expenditure | -1,228.23% | -27.52% | -414.34% | -414.34% | 79.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,228.23% | -1,325.55% | -413.11% | -413.11% | 92.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 73.76% | 49.75% | -115.30% | -115.30% | -8,155.32% |
| Issuance of Common Stock | -86.68% | 41.84% | -100.00% | -100.00% | 19.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.36% | -115.91% | -118.56% | -118.56% | -166.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 851.14% | 3,859.42% | 3,286.01% | 3,286.01% | 164.76% |